完整血管紧张素原与危重症死亡率的关联强于乳酸或肾素:VICTAS试验的事后分析
本研究为VICTAS试验的事后分析,在脓毒症患者基线(第0天)比较血清血管紧张素原、肾素和乳酸与30天死亡率的关联,采用ROC曲线和Kaplan-Meier曲线分析。结果显示,血清血管紧张素原浓度与30天死亡率的关联强于肾素或乳酸。作者认为,血管紧张素原的临床评估可能优于常规肾素检测,完整血管紧张素原的评估可能有助于更精准的治疗(包括外源性血管紧张素II)以恢复功能失调的肾素-血管紧张素系统并改善预后。但作者明确指出,该生物标志物未来仍需额外的前瞻性验证研究。
要点
- 在VICTAS脓毒症队列基线(第0天),血清血管紧张素原与30天死亡率的关联强于肾素或乳酸。
- 作者认为,血管紧张素原的临床评估可能优于常规肾素检测。
- 作者提出,完整血管紧张素原的评估可能有助于更精准的治疗(包括外源性血管紧张素II)以恢复功能失调的RAS。
- 作者明确指出,该生物标志物未来仍需额外的前瞻性验证研究。
适用人群与场景
- VICTAS试验队列中的脓毒症患者,基线为第0天
研究设计与关键结果
- 研究类型:VICTAS试验的事后分析;人群:VICTAS队列脓毒症患者;比较指标:基线(第0天)血清血管紧张素原、肾素、乳酸;主要分析:ROC曲线和Kaplan-Meier曲线分析;主要结果:血清血管紧张素原浓度与30天死亡率的关联强于肾素或乳酸。
证据类型、等级与局限
- 证据类型:VICTAS试验的事后分析;局限:作者指出该生物标志物未来仍需额外的前瞻性验证研究。
对床旁实践的改变
- 作者认为,血管紧张素原的临床评估可能优于常规肾素检测。
- 作者提出,完整血管紧张素原的评估可能有助于更精准的治疗(包括外源性血管紧张素II)以恢复功能失调的RAS并改善预后。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Sepsis and septic shock remain global healthcare problems associated with high mortality rates despite best therapy efforts. Circulating biomarkers may identify those patients at risk for poor outcomes, however, current biomarkers, most prominently lactate, are non-specific and have an inconsistent impact on prognosis and/or disease management. Activation of the renin-angiotensin- system (RAS) is an early event in sepsis patients and elevated levels of circulating renin are more predictive of worse outcomes than lactate. The precursor protein Angiotensinogen is another key component of the circulating RAS; it is the only known substrate for renin and the ultimate source of the vasopressor Angiotensin II (Ang II). We postulate that lower Angiotensinogen concentrations may reflect a dysfunctional RAS characterized by high renin concentrations but attenuated Ang II generation, which is disproportionate to the high renin response and may compromise adequate support of blood pressure and tissue perfusion in septic patients. The current study compared the association between serum Angiotensinogen with mortality to that of lactate and renin in the VICTAS cohort of sepsis patients at baseline (day 0) by receiver operating characteristic (ROC) and Kaplan-Meier curve analyses. Serum concentration of Angiotensinogen was more strongly associated with 30-day mortality than either the serum concentrations of renin or lactate in sepsis patients. Moreover, the clinical assessment of Angiotensinogen may have distinct advantages over the typical measures of renin. The assessment of intact Angiotensinogen may potentially facilitate more precise therapeutic approaches (including exogenous angiotensin II) to restore a dysfunctional RAS and improve patient outcomes. Additional prospective validation studies are clearly required for this biomarker in the future.
参考来源
- Chappell MC, Schaich CL, Busse LW, et al. Stronger association of intact angiotensinogen with mortality than lactate or renin in critical illness: post-hoc analysis from the VICTAS trial. Crit Care. 2024. PMID: 39402593. doi:10.1186/s13054-024-05120-w
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。